- Home
- OMEX vs NXL Comparison
OMEX vs NXL Comparison
Compare OMEX & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMEX
- NXL
- Stock Information
- Founded
- OMEX 1986
- NXL 2010
- Country
- OMEX United States
- NXL United States
- Employees
- OMEX N/A
- NXL N/A
- Industry
- OMEX Marine Transportation
- NXL Medical Specialities
- Sector
- OMEX Consumer Discretionary
- NXL Health Care
- Exchange
- OMEX Nasdaq
- NXL Nasdaq
- Market Cap
- OMEX 9.3M
- NXL 10.0M
- IPO Year
- OMEX N/A
- NXL 2022
- Fundamental
- Price
- OMEX $0.36
- NXL $2.63
- Analyst Decision
- OMEX
- NXL Hold
- Analyst Count
- OMEX 0
- NXL 1
- Target Price
- OMEX N/A
- NXL N/A
- AVG Volume (30 Days)
- OMEX 4.5M
- NXL 542.2K
- Earning Date
- OMEX 02-19-2025
- NXL 11-08-2024
- Dividend Yield
- OMEX N/A
- NXL N/A
- EPS Growth
- OMEX N/A
- NXL N/A
- EPS
- OMEX N/A
- NXL N/A
- Revenue
- OMEX $799,139.00
- NXL $162,078.00
- Revenue This Year
- OMEX N/A
- NXL $56.86
- Revenue Next Year
- OMEX N/A
- NXL $167.44
- P/E Ratio
- OMEX $0.62
- NXL N/A
- Revenue Growth
- OMEX N/A
- NXL 26.00
- 52 Week Low
- OMEX $0.30
- NXL $0.25
- 52 Week High
- OMEX $5.57
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- OMEX 41.76
- NXL 33.77
- Support Level
- OMEX $0.31
- NXL $2.92
- Resistance Level
- OMEX $0.40
- NXL $4.49
- Average True Range (ATR)
- OMEX 0.07
- NXL 0.40
- MACD
- OMEX 0.01
- NXL -0.24
- Stochastic Oscillator
- OMEX 17.48
- NXL 4.32
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.